MD Anderson Cancer Center IOTOX Clinical Educational Symposium

1. Outline the guideline recommendations for each toxicity;
2. Identify patient treatment plans to evaluate difficult patient circumstances as it pertains to IOTOX; and
3. Provide treatment plans and IOTOX guidelines to all providers including APPs, Nurses and Trainees.
4. Identify location and use of national societies guidelines for IOTOX;
5. Implement IOTOX guidelines that are vetted by both oncologists and internal medicine specialists;

The MDACC IOTOX Clinical Education Symposium, will begin at 8:00 am on Saturday, December 3, 2022 and the symposium will conclude at 4:30 pm. Advanced registration is encouraged as space is limited.  Please see registration form for applicable fees.

Advanced registration is encouraged and you can choose to attend in person or to attend via Zoom.

REGISTRATION IS NOW CLOSED

Fees:

We accept the following forms of payment:
  •Credit Cards (MasterCard, VISA, and American Express)
  •Check (Payable to The University of Texas MD Anderson Cancer Center; through U.S. banks only)

Mail checks to:
   Continuing Professional Education (CPE) – Unit 1781
   The University of Texas MD Anderson Cancer Center
   P.O. Box 301407
   Houston, Texas 77230-1407

When registering online a receipt (confirmation letter) will be automatically emailed to the e-mail address you list on the registration form.  The Zoom ID and Password will be communicated via email 72 hours before the symposium start time. Video recording of the event will be available online for 30 days after the symposium. CME credit will not be awarded for viewing the video recordings.

Telephone registrations are not accepted.

Refund/Cancellation Policy
The registration fee, minus a $25 administration-handling fee, is refundable if a written request is received on or before November 12, 2022. No refunds will be granted after these dates. The request for a registration refund must include the tax identification number of the company or institution if registration was paid by a company or institution check. 

The Department of Continuing Professional Education (CPE), reserves the right to cancel activities prior to the scheduled date, if low enrollment or other circumstances make it necessary.  Each registrant will be notified by mail, e-mail, or at the phone or fax numbers given on the registration form. In case of activity cancellation, the liability of the CPE is limited to the registration fee. CPE will refund the full registration fee. 

CPE reserves the right to limit the number of participants in an activity and is not responsible for any expenses incurred by an individual whose registration is not confirmed and for whom space is not available. 

For additional information or Special Assistance, contact CPE at 713-792-2223 or toll free at 866-849-5866 or via e-mail: [email protected].

Evaluation
A course evaluation tool will provide participants with the opportunity to comment on the value of the program content to their practice decisions, performance improvement activities, or possible impact on patient health status. Participants will also have the opportunity to comment on any perceived commercial bias in the presentations as well as to identify future educational topics.  The survey link will be provided during the review course.

AMERICAN BOARD OF INTERNAL MEDICINE (ABIM)
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 6.75 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Participant completion data will be shared with and transmitted to the ACCME on the participant’s behalf.  In order to receive MOC points, you must pass the post-test with a score of 70% or higher. 

View the accessibility policy for The University of Texas M.D Anderson Cancer Center.

The University of Texas MD Anderson Cancer Center complies with all requirements of the identified accrediting body  (ACCME, ANCC, ACPE). Disclosure of speakers, faculty members, planning committee members and their commercial relationships will be shared with learners prior to the educational activity.

Mitigation of Relevant Financial Relationships

Member Information

Role in activity

Nature of Relationship(s) / Name of Ineligible Company(s)

Eric Gagneaux
Continuing Education Planner
MD Anderson Cancer Center

Activity Administrator

Non-Clinical Exception

Dhanalakshmi Koyyalagunta, MD
Professor
University of Texas MD Anderson Cancer Center

CE Reviewer

Grant or research support-Lucid Lane

Bilal A. Siddiqui, MD
Assistant Professor
The University of Texas MD Anderson Cancer Center

Co-Director, Faculty

Nothing to disclose

Yinghong Wang, MD
Professor, Gastroenterology Hepation & Nutrition
The University of Texas MD Anderson Cancer Center

Co-Director, Faculty

Consulting Fee-Sorriso Pharma|Consulting Fee-MabQuest|Consulting Fee-AzurRx

Ala Abudayyeh, MD
Professor
MD Anderson Cancer Center

Faculty

Nothing to disclose

Nagham Al-Zubidi, MD, Ophthalmology/ Neuro-Ophthalmology
Assistant Professor
MD Anderson Cancer Center

Faculty

Nothing to disclose

Rodabe N. Amaria, MD
Associate Professor, Melanoma Medical Oncology
The University of Texas MD Anderson Cancer Center

Faculty

Grant or research support-Novartis Pharmaceuticals Corporation|Grant or research support-Merck Sharp & Dohme Corp. (any division)|Grant or research support-Bristol-Myers Squibb Company|Grant or research support-Lovance|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Novartis Pharmaceuticals Corporation|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Bristol-Myers Squibb Company|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Lovance|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Nektar

Conor J. Best, MD
Assistant Professor
MD Anderson Cancer Center

Faculty

Consulting Fee-Novartis Pharmaceuticals Corporation (Relationship has ended)

Julie R Brahmer, MD
Director, Thoracic Oncology Program & Professor of Oncology
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Faculty

Membership on Advisory Committees or Review Panels, Board Membership, etc.-Amgen Inc.|Membership on Advisory Committees or Review Panels, Board Membership, etc.-AstraZeneca US|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Bristol-Myers Squibb Company|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Roche|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Genentech, Inc.|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Lilly USA, LLC|Membership on Advisory Committees or Review Panels, Board Membership, etc.-GlaxoSmithKline|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Merck Sharp & Dohme Corp. (any division)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Sanofi US|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Regeneron Pharmaceuticals, Inc.|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Janssen Biotech, Inc.|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Johnson & Johnson|Grant or research support-AstraZeneca US|Grant or research support-Bristol-Myers Squibb Company|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Janssen Biotech, Inc.

Norman Brito Dellan, MD
Associate Professor
MD Anderson Cancer Center

Faculty

Nothing to disclose

Adi Diab, MD
Associate Professor
MD Anderson Cancer Center

Faculty

Consulting Fee-Lytix Biopharma|Consulting Fee-Nektar Therpaeutics|Consulting Fee-Idera Pharmaceuticals|Consulting Fee-Apexigen

Ecaterina E. Dumbrava, MD
Assistant Professor - Invest. Cancer Therapeutics
MD Anderson Cancer Center

Faculty

Advisor-BOLT Therapeutics|Advisor-Mersana

Maria C Franco Vega, MD, FACP
Assistant Professor
MD Anderson Cancer Center

Faculty

Nothing to disclose

Maria Gaeta, MD, FACP, MSHCT
Associate Professor
University of Texas MD Anderson Cancer Center

Faculty

Nothing to disclose

Priyanka C. Iyer, MD
Assistant Professor
The University of Texas MD Anderson Cancer Center

Faculty

Nothing to disclose

Douglas B Johnson, MD
Associate Professor of Medicine
Vanderbilt University Medical Center

Faculty

Advisor-Bristol-Myers Squibb Company|Advisor-Merck Sharp & Dohme Corp. (any division)|Advisor-Novartis Pharmaceuticals Corporation|Advisor-Mallinckrodt Pharmaceuticals (Relationship has ended)|Advisor-Targovax|Advisor-Teiko|Advisor-Iovance|Advisor-Mosaic ImmunoEngineering|Advisor-Pfizer Inc.

Jamie S. Lin, MD
Assistant Professor
MD Anderson Cancer Center

Faculty

Nothing to disclose

Huifang Lu, MD
Professor
MD Anderson Cancer Center

Faculty

Nothing to disclose

Joanna Grace Manzano, MD
Associate Professor
MD Anderson Cancer Center

Faculty

Nothing to disclose

Ellen F. Manzullo, MD
Professor of Medicine
UT MD Anderson Cancer Center

Faculty

Nothing to disclose

Jennifer L. McQuade, MD
Assistant Professor
MD Anderson Cancer Center

Faculty

Honoraria-Merck Sharp & Dohme Corp. (any division)

Michel Obeid, MD, PhD
Responsible of LCIT Center
CHUV, Lausanne, Switzerland
Switzerland

Faculty

Nothing to disclose

Thein H Oo, MD, FRCP, FACP
Professor
MD Anderson Cancer Center

Faculty

Nothing to disclose

Nicolas Palaskas, MD
Assistant Professor
MD Anderson Cancer Center

Faculty

Consulting Fee-Kiniksa Pharmaceuticals|Honoraria-Scripps (Relationship has ended)|Honoraria-Society of Immunotherapy for Cancer (Relationship has ended)|Consulting Fee-Replimmune|Honoraria-Patient Education Resource (Relationship has ended)

Anisha Patel, MD
Associate Professor
MD Anderson Cancer Center

Faculty

Grant or research support-Pfizer Inc.|Grant or research support-OnQuality|Grant or research support-Lutris|Paid consultant-Deciphera|Paid consultant-Novartis Pharmaceuticals Corporation (Relationship has ended)|Consulting Fee-Repare Therapeutics

Alice Saji, DNP
Advanced Practice Registered Nurse
The University of Texas MD Anderson Cancer Center

Faculty

Nothing to disclose

Bryan Schneider, MD
Professor of Medicine
University of Michigan

Faculty

Nothing to disclose

Amishi Y. Shah, MD
Assistant Professor
The University of Texas MD Anderson Cancer Center

Faculty

Grant or research support-Bristol-Myers Squibb Company|Grant or research support-EMD Serono Inc.|Grant or research support-Eisai, Inc. (Relationship has ended)|Grant or research support-4D pharma|Advisor-Bristol-Myers Squibb Company (Relationship has ended)|Advisor-exelixis (Relationship has ended)|Advisor-Pfizer Inc. (Relationship has ended)

Ajay Sheshadri, MD
Assistant Professor
The University of Texas MD Anderson Cancer Center

Faculty

Membership on Advisory Committees or Review Panels, Board Membership, etc.-Enanta Pharmaceuticals

Anusha Anusha Shirwaikar Thomas, MD
Assistant Professor
The University of Texas MD Anderson Cancer Center

Faculty

Nothing to disclose

John Thompson, MD
Professor
University of Washington

Faculty

Consulting Fee-MabQuest|Honoraria-Regeneron Pharmaceuticals, Inc. (Relationship has ended)|Grant or research support-Pfizer Inc.|Grant or research support-Xencor|Grant or research support-Novartis Pharmaceuticals Corporation|Grant or research support-PMV

Sudhakar Tummala, MD
Professor
MD Anderson Cancer Center

Faculty

Nothing to disclose

David J. Tweardy, MD
Division Head
MD Anderson Cancer Center

Faculty

Nothing to disclose

Susan Varghese, PhD
APRN
MD Anderson Cancer Center

Faculty

Nothing to disclose

Lan S. Wang, MD
Assistant Professor
MD Anderson Cancer Center

Faculty

Nothing to disclose

Hao Chi Zhang, MD
Assistant Professor
MD Anderson Cancer Center

Faculty

Nothing to disclose

Sarah Fayle, MA, MS
Director, Division of Internal Medicine Administration
MD Anderson Cancer Center

Faculty, Other Planning Committee Member

Non-Clinical Exception

Anishia Rawther-Karedath, MSN
Supervisor, APP
MD Anderson Cancer Center

Faculty, Other Planning Committee Member

Nothing to disclose

Mianen Sun, PhD
Director, Research Planning and Development
MD Anderson Cancer Center

Other Planning Committee Member

Nothing to disclose